UBS Maintains a 'Buy' on Dyax Corp. (DYAX); Q4: Tempering Our Kalbitor Expectations
Tweet Send to a Friend
UBS maintains a 'Buy' on Dyax Corp. (NASDAQ: DYAX), lowers PT from $5 to $4.
UBS analyst says, "DYAX reports ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst says, "DYAX reports ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
